Education
About Us
Working with TipRanks
Follow Us
China Isotope & Radiation Corp. (HK:1763)
:1763
RESEARCH TOOLSreports
1763 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$9.30 - HK$16.80
Previous CloseN/A
Volume52.80K
Average Volume (3M)691.33K
Market Cap
HK$4.75B
Enterprise ValueHK$1.74B
Total Cash (Recent Filing)HK$2.63B
Total Debt (Recent Filing)¥2.57B
Price to Earnings (P/E)10.8
Beta0.82
Next Earnings
Aug 29, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 05, 2025Dividend Yield4.54%
Share Statistics
EPS (TTM)1.38
Shares Outstanding79,968,800
10 Day Avg. Volume804,800
30 Day Avg. Volume691,326
Financial Highlights & Ratios
PEG Ratio0.60
Price to Book (P/B)0.85
Price to Sales (P/S)0.00
P/FCF Ratio11.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
China Isotope & Radiation Corp. News
PremiumCompany Announcements
CIRC Donates Medical Equipment to Enhance Healthcare in Baihe County
PremiumCompany Announcements
China Isotope & Radiation Corp. Launches First Irradiation Project in Peru
PremiumCompany Announcements
China Isotope & Radiation Corp. Announces Board Composition and Roles
PremiumCompany Announcements
CIRC Enhances Governance with New Shareholder Meeting Rules
PremiumCompany Announcements
China Isotope & Radiation Corp. Enhances Board Governance
PremiumCompany Announcements
China Isotope & Radiation Corp. Forms Audit and Risk Management Committee
PremiumCompany Announcements
China Isotope & Radiation Corp. Approves Key Resolutions at AGMOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.51%
Mutual Funds
― Other Institutional Investors
99.47% Public Companies and
Individual Investors
1763 FAQ
What was China Isotope & Radiation Corp.’s price range in the past 12 months?
China Isotope & Radiation Corp. lowest stock price was HK$9.30 and its highest was HK$16.80 in the past 12 months.
What is China Isotope & Radiation Corp.’s market cap?
China Isotope & Radiation Corp.’s market cap is HK$4.75B.
When is China Isotope & Radiation Corp.’s upcoming earnings report date?
China Isotope & Radiation Corp.’s upcoming earnings report date is Aug 29, 2025 which is in 67 days.
How were China Isotope & Radiation Corp.’s earnings last quarter?
China Isotope & Radiation Corp. released its earnings results on Mar 28, 2025. The company reported HK$0.855 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.855.
Is China Isotope & Radiation Corp. overvalued?
According to Wall Street analysts China Isotope & Radiation Corp.’s price is currently Overvalued.
Does China Isotope & Radiation Corp. pay dividends?
China Isotope & Radiation Corp. pays a Semiannually dividend of HK$0.337 which represents an annual dividend yield of 4.54%. See more information on China Isotope & Radiation Corp. dividends here
What is China Isotope & Radiation Corp.’s EPS estimate?
China Isotope & Radiation Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Isotope & Radiation Corp. have?
China Isotope & Radiation Corp. has 79,968,800 shares outstanding.
What happened to China Isotope & Radiation Corp.’s price movement after its last earnings report?
China Isotope & Radiation Corp. reported an EPS of HK$0.855 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.789%.
Which hedge fund is a major shareholder of China Isotope & Radiation Corp.?
Currently, no hedge funds are holding shares in HK:1763
China Isotope & Radiation Corp. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
50.29%
12-Months-Change
Fundamentals
Return on Equity
8.40%
Trailing 12-Months
Asset Growth
8.20%
Trailing 12-Months
Company Description
China Isotope & Radiation Corp.
China Isotope & Radiation Corporation (CIRC) is a prominent player in the nuclear technology industry, focusing on the production and supply of isotopes and related products. The company operates primarily in sectors such as nuclear medicine, radiation processing, and nuclear technology applications. CIRC provides a wide array of products and services, including medical isotopes, radiopharmaceuticals, radiation equipment, and irradiation services, which are essential for medical diagnostics, treatment, and various industrial applications.
Technical Analysis
Ping An Insurance Company of China
―
Sino Biopharmaceutical
―
Sinopharm Group Co
―
Shanghai Fosun Pharmaceutical (Group) Co
―
Livzon Pharmaceutical Group
―